Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Crude Oil Moves Lower; NLS Pharmaceutics Shares Jump

Author: Avi Kapoor | July 29, 2024 12:03pm

U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining around 0.4% on Monday.

The Dow traded up 0.02% to 40,598.43 while the NASDAQ rose 0.40% to 17,427.58. The S&P 500 also rose, gaining, 0.28% to 5,474.27.

Check This Out: Top 4 Energy Stocks That May Rocket Higher In Q3

Leading and Lagging Sectors

Consumer discretionary shares jumped by 1% on Monday.

In trading on Monday, energy shares fell by 1.3%.

Top Headline

ON Semiconductor Corp (NASDAQ:ON) reported better-than-expected second quarter financial results.

ON Semiconductor reported a fiscal second-quarter 2024 revenue decline of 17.2% year-on-year to $1.74 billion, beating the analyst consensus estimate of $1.73 billion. The adjusted EPS of 96 cents beat the analyst consensus estimate of 92 cents per share, according to data from Benzinga Pro.

Equities Trading UP
                       

  • Lipella Pharmaceuticals Inc. (NASDAQ:LIPO) shares shot up 127% to $0.9334 after the company announced it commenced its Phase 2a trial for LP-310 in Oral Lichen Planus.
  • Shares of NLS Pharmaceutics AG (NASDAQ:NLSP) got a boost, surging 54% to $0.2794 after the company announced a merger in which Kadimastem will become a wholly owned subsidiary of NLS.
  • Venus Concept Inc. (NASDAQ:VERO) shares were also up, gaining 16% to $0.75 after the company received a medical device license from Health Canada to market its Venus Bliss MAX system.

Equities Trading DOWN

  • vTv Therapeutics Inc. (NASDAQ:VTVT) shares dropped 31% to $14.65 after the company announced the FDA has placed a clinical hold on the cadisegliatin clinical program.
  • Shares of Cognition Therapeutics, Inc. (NASDAQ:CGTX) were down 35% to $1.5499 after the company reported Phase 2 results for Alzheimer’s drug.
  • Ventyx Biosciences, Inc. (NASDAQ:VTYX) was down, falling 25% to $2.22. The company released results from the Phase 2 trial of allosteric TYK2 inhibitor VTX958 in participants with moderately to severely active Crohn's disease, a type of inflammatory bowel disease that irritates and causes swelling in digestive tract.

Also Check This Out: This Analyst With 84% Accuracy Rate Sees More Than 10% Upside In Apple – Here Are 5 Stock Picks For Last Week From Wall Street’s Most Accurate Analysts

Commodities

In commodity news, oil traded down 1.9% to $75.71 while gold traded down 0.4% at $2,371.10.

Silver traded down 1.6% to $27.575 on Monday, while copper fell 1.4% to $4.0670.

Euro zone

European shares were mostly lower today. The eurozone's STOXX 600 fell 0.23%, Germany's DAX fell 0.58% and France's CAC 40 fell 0.99%. Spain's IBEX 35 Index fell 0.48%, while London's FTSE 100 rose 0.17%.

UK's net consumer credit increased by £1.2 billion over a month during June, a decline from the £1.5 billion gain recorded in May.

Asia Pacific Markets

Asian markets closed higher on Monday, with Japan's Nikkei 225 surging 2.13%, Hong Kong's Hang Seng Index gaining 1.28%, China's Shanghai Composite Index gaining 0.03% and India's S&P BSE Sensex rising 0.03%.

Singapore's Domestic Supply Price Index increased by 4.3% year-over-year in June, accelerating from a revised 2.7% gain in the prior month. Producer prices in Malaysia increased to 1.6% year-over-year for June. Profits earned by Chinese industrial firms climbed by 3.5% year-over-year to CNY 3,511.03 billion during the first six months of 2024.

Economics

The Dallas Fed Manufacturing index declined to -17.5 in July versus a reading of -15.1 in the prior month.

Now Read This: Northrop Grumman To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday

Posted In: CGTX LIPO NLSP ON VERO VTVT VTYX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist